EGFR, HER2, and HER3 Expression in Laryngeal Primary Tumors and Corresponding Metastases
Authors:
- 3 January 2008
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (4) , 1193-1201
Abstract
Background There are several substances available to target members of the epidermal growth factor receptor (EGFR) family, both for imaging in nuclear medicine and for various forms of therapy. The...Keywords
This publication has 38 references indexed in Scilit:
- Differential prognostic impact of comorbidity in head and neck cancerHead & Neck, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Prognostic significance of vascular endothelial growth factor protein levels in T1‐2 N0 laryngeal cancer treated with primary radiation therapyCancer, 2006
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patientsBritish Journal of Cancer, 2006
- Pharmacodiagnostic Value of the HER Family in Head and Neck Squamous Cell CarcinomaORL, 2004
- C-erbB-2 Immunostaining in Laryngeal CancerActa Oto-Laryngologica, 1999
- Glottic and Supraglottic Laryngeal Carcinoma: Differences in Epidemiology, Clinical Characteristics and PrognosisActa Oto-Laryngologica, 1999
- Epidermal growth factor receptor immunoreactivity in human laryngeal squamous cell carcinomaPathology, 1997
- GROWTH FACTOR RECEPTOR TYROSINE KINASESAnnual Review of Biochemistry, 1988